Thrombotic microangiopathies in critically ill children: The MATUCIP registry in Spain

An Pediatr (Engl Ed). 2023 Mar;98(3):194-203. doi: 10.1016/j.anpede.2023.02.006. Epub 2023 Feb 25.

Abstract

Introduction: Thrombotic microangiopathies (TMA) are rare diseases usually presenting with renal, haematological, neurologic and cardiovascular involvement and nonspecific but severe symptoms. A registry of TMA cases managed in Spanish paediatric intensive care units (the MATUCIP Registry) was established with the aim of gaining knowledge on their clinical characteristics, diagnosis and acute-phase treatment.

Methods: We conducted a prospective multicentre observational study in 20 paediatric intensive care units (PICUs) in Spain from January 2017 to December 2021 in children aged more than 1 month with TMAs, who were followed up through the discharge from the PICU.

Results: The sample included 97 patients (51.5% female) with a median age of 2.6 years (interquartile range [IQR], 1.6-5.7). The initial manifestations were gastrointestinal (74.2%), respiratory (14.4%), fever (5.2%), neurologic (3.1%) and other (3.1%). At admission, 75.3% of patients had microangiopathic haemolytic anaemia, 95.9% thrombocytopenia and 94.8% acute kidney injury. Of the total sample, 57.7% of patients received a diagnosis of Shiga toxin-associated haemolytic uraemic syndrome (HUS), 14.4% of Streptococcus pneumoniae-associated HUS, 15.6% of atypical HUS, 10.3% of secondary TMA and 2.1% of thrombotic thrombocytopenic purpura. Eighty-seven patients (89.7%) developed arterial hypertension, and 49.5% gastrointestinal, 22.7% respiratory, 25.8% neurologic and 12.4% cardiac manifestations. Also, 60.8% required renal replacement therapy and 2.1% plasma exchange. Twenty patients received eculizumab. The median PICU stay was 8.5 days (IQR, 5-16.5). Two children died.

Conclusions: The MATUCIP registry demonstrates the clinical variability of TMA cases requiring admission to the PICU. Knowledge of the presentation and outcomes of TMAs can facilitate early aetiological diagnosis. This registry can help improve our understanding of the clinical spectrum of these diseases, for which there is a dearth of published data.

Keywords: Acute kidney injury; Anemia hemolítica microangiopática; Cuidados intensivos pediátricos; Haemolytic uraemic syndrome; Insuficiencia renal aguda; Microangiopathic haemolytic anaemia; Microangiopatía trombótica; Paediatricintensive care; Síndrome hemolítico urémico; Thrombocytopenia; Thrombotic microangiopathy; Trombocitopenia.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Atypical Hemolytic Uremic Syndrome* / diagnosis
  • Atypical Hemolytic Uremic Syndrome* / etiology
  • Atypical Hemolytic Uremic Syndrome* / therapy
  • Child
  • Child, Preschool
  • Critical Illness / therapy
  • Female
  • Humans
  • Male
  • Plasma Exchange / adverse effects
  • Spain / epidemiology
  • Thrombotic Microangiopathies* / diagnosis
  • Thrombotic Microangiopathies* / epidemiology
  • Thrombotic Microangiopathies* / therapy